19 stories tagged #pancreatic cancer

  1. Stade Brestois Manager Eric Roy Dies at 58 Following Champions League Triumph
    sports

    Stade Brestois Manager Eric Roy Dies at 58 Following Champions League Triumph

    Eric Roy, the Stade Brestois manager who led the club to its first UEFA Champions League qualification while battling pancreatic cancer, has died at age 58.

    6d ago 1 min read
  2. Stade Brestois Coach Eric Roy Dies at 58 After Cancer Battle
    sports

    Stade Brestois Coach Eric Roy Dies at 58 After Cancer Battle

    Stade Brestois manager Eric Roy has died at 58 following a private battle with pancreatic cancer, leaving behind a legacy of historic European qualification.

    6d ago 1 min read
  3. Breakthrough Pancreatic Cancer Drug Shows Surprising Survival Gains
    health

    Breakthrough Pancreatic Cancer Drug Shows Surprising Survival Gains

    A new pancreatic cancer pill nearly doubles survival time in a groundbreaking trial, offering new hope against one of the deadliest cancers.

    2w ago 1 min read
  4. Pancreatic Cancer Pill Doubles Survival, Canada Trial Eyed
    health

    Pancreatic Cancer Pill Doubles Survival, Canada Trial Eyed

    A daily pill, daraxonrasib, doubles survival for pancreatic cancer patients. Canadian doctors seek clinical trials.

    2w ago 1 min read
  5. New Pancreatic Cancer Pill Shows Promise, 90% of Patients Respond in Early Trial
    health

    New Pancreatic Cancer Pill Shows Promise, 90% of Patients Respond in Early Trial

    An experimental daily pill, daraxonrasib, shows a 90% disease control rate in advanced pancreatic cancer patients during early-stage clinical trials.

    last mo. 2 min read
  6. Pan-RAS Inhibitor Shows Survival Gain in Pancreatic Cancer
    health

    Pan-RAS Inhibitor Shows Survival Gain in Pancreatic Cancer

    Daraxonrasib, a pan-RAS inhibitor, demonstrated improved survival and tumor control in advanced pancreatic cancer in early trials.

    last mo. 1 min read
  7. Experimental Pancreatic Cancer Drug Daraxonrasib Nears Approval, Shows Surge in Demand
    health

    Experimental Pancreatic Cancer Drug Daraxonrasib Nears Approval, Shows Surge in Demand

    Daraxonrasib nearly doubles survival in trials, now in early access amid high demand before full FDA approval.

    last mo. 1 min read
  8. Hope for Pancreatic Cancer Patients as New Drug Shows Promise
    health

    Hope for Pancreatic Cancer Patients as New Drug Shows Promise

    Revolution Medicines' daraxonrasib doubles survival in advanced pancreatic cancer, sparking patient demand and FDA compassionate use access.

    last mo. 1 min read